GLP-1 Monoclonal Antibody (49), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | ABS0444902-Each-of-1 | In Stock | ₹ 1,19,441.76 |
ABS0444902 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 1,19,441.76
GST (18%): ₹ 21,499.517
Total Price: ₹ 1,40,941.277
Antigen
GLP-1
Classification
Monoclonal
Concentration
1.03 mg/mL
Formulation
PBS with 15mM sodium azide; pH 7.4
Gene Accession No.
P01275
Gene Symbols
GCG
Immunogen
Synthetic GLP-1(9-18) adsorbed onto aluminum hydroxide gel.
Quantity
400 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG1 κ
Applications
ELISA, Western Blot
Clone
49
Conjugate
Unconjugated
Gene
GCG
Gene Alias
GCG; Glicentin; Glicentin-related polypeptide; GLP1; GLP-1; GLP-1(7-36); GLP-1(7-37); GLP1/2; GLP2; GLP-2; Glu; glucagon; Glucagon like peptide 1; Glucagon-like peptide 1; Glucagon-like peptide 1(7-36); Glucagon-like peptide 1(7-37); Glucagon-like peptide 2; glucagon-like peptide-1; GRPP; Incretin hormone; MGC138331; OXM; OXY; Oxyntomodulin; PPG; preproglucagon
Host Species
Mouse
Purification Method
Protein A/G
Regulatory Status
RUO
Gene ID (Entrez)
2641
Content And Storage
4° C, store in dark
Form
Liquid
Related Products
Description
- ABS 044-49-02 binds human GLP-1 (9-36) amide
- Based on inhibition ELISA, this antibody cross-reacts at 3% with GLP-1 (7-36) amide
- Reactivity: ABS 044-49-02 binds free GLP-1 (9-36) amide in solution
- NOTE: Concentration is lot-dependent and can vary from 0.85-1.15 mg/mL GCG is also known as GLP1, or Glucagon
- Glucagon is a 29-amino acid pancreatic hormone that counteracts the glucose-lowering action of insulin by stimulating glycogenolysis and gluconeogenesis.It is mapped to 2q36-2q37
- GLP1, also known as 7-37 for the codons of the preproglucagon molecule which encode it, renders pancreatic beta-cells 'glucose-competent' and may be useful in the treatment of noninsulin-dependent diabetes mellitus
- Also, GLP1 is a potent insulin secretagogue.It plays a major role in the enteroinsular axis, accounting, for example, for the finding that plasma insulin levels accompanying oral intake of glucose are greater than those observed when glucose is given intravenously.